• Featured Product
  • KD/KO Validated

RBBP9 Monoklonaler Antikörper

RBBP9 Monoklonal Antikörper für WB, IHC, FC (Intra), Indirect ELISA

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

Hausschwein, human, Maus, Ratte

Anwendung

WB, IHC, FC (Intra), Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

3D5E11

Kat-Nr. : 66015-2-PBS

Synonyme

3D5E11, B5T-overexpressed gene protein, BOG, EC:3.-.-.-, Glutathione S-Transferase



Geprüfte Anwendungen

Produktinformation

66015-2-PBS bindet in WB, IHC, FC (Intra), Indirect ELISA RBBP9 und zeigt Reaktivität mit Hausschwein, human, Maus, Ratten

Getestete Reaktivität Hausschwein, human, Maus, Ratte
Wirt / Isotyp Maus / IgG2b
Klonalität Monoklonal
Typ Antikörper
Immunogen RBBP9 fusion protein Ag17864
Vollständiger Name retinoblastoma binding protein 9
Berechnetes Molekulargewicht 186 aa, 21 kDa
Beobachtetes Molekulargewicht 22 kDa
GenBank-ZugangsnummerBC015938
Gene symbol RBBP9
Gene ID (NCBI) 10741
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

RBBP9, also named as BOG, RBBP10, RBBP-9, RBBP-10 and Protein BOG, belongs to the RBBP9 family. It may play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-β1 through interaction with retinoblastoma and the subsequent displacement of E2F-1. RBBP9 is a tumor-associated serine hydrolase activity required for pancreatic neoplasia. It mediates suppression of TGF-β signaling is required for E-cadherin expression as loss of the serine hydrolase activity leads to a reduction in E-cadherin levels and a concomitant decrease in the integrity of tumor cell-cell junctions..RBBP9 protein levels were equivalent in paired primary tumor and nonneoplastic specimens(PMID:20080647)